• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期血浆干扰素-β水平可作为预测成年 COVID-19 患者严重临床事件的标志物。

Early plasma interferon-β levels as a predictive marker of COVID-19 severe clinical events in adult patients.

机构信息

EA4684 Cardiovir Research Laboratory, University of Reims Champagne-Ardenne, Reims, France.

Internal Medicine, Infectious Diseases and Clinical Immunology, Robert Debré University Hospital, Reims, France.

出版信息

J Med Virol. 2023 Jan;95(1):e28361. doi: 10.1002/jmv.28361.

DOI:10.1002/jmv.28361
PMID:36451263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9877952/
Abstract

We assessed relationships between early peripheral blood type I interferons (IFN) levels, clinical new early warning scores (NEWS), and clinical outcomes in hospitalized coronavirus disease-19 (COVID-19) adult patients. Early IFN-β levels were lower among patients who further required intensive care unit (ICU) admission than those measured in patients who did not require an ICU admission during severe acute respiratory syndrome coronavirus type 2 infection. IFN-β levels were inversely correlated with NEWS only in the subgroup of patients who further required ICU admission. To assess whether peripheral blood IFN-β levels could be a potential relevant biomarker to predict further need for ICU admission, we performed receiver operating characteristic (ROC) curve analyses that showed for all study patients an area under ROC curve of 0.77 growing to 0.86 (p = 0.003) when the analysis was restricted to a subset of patients with NEWS ≥5 at the time of hospital admission. Overall, our findings indicated that early peripheral blood IFN-β levels might be a relevant predictive marker of further need for an ICU admission in hospitalized COVID-19 adult patients, specifically when clinical score (NEWS) was graded as upper than 5 at the time of hospital admission.

摘要

我们评估了住院的 2019 冠状病毒病(COVID-19)成年患者早期外周血 I 型干扰素(IFN)水平、临床新早期预警评分(NEWS)与临床结局之间的关系。与严重急性呼吸综合征冠状病毒 2 型感染期间不需要入住重症监护病房(ICU)的患者相比,进一步需要 ICU 收治的患者早期 IFN-β水平较低。IFN-β水平仅与进一步需要 ICU 收治的患者亚组的 NEWS 呈负相关。为评估外周血 IFN-β水平是否可作为预测进一步需要 ICU 收治的潜在相关生物标志物,我们进行了受试者工作特征(ROC)曲线分析,结果显示对于所有研究患者,当分析仅限于入院时 NEWS≥5 的患者亚组时,ROC 曲线下面积从 0.77 增长到 0.86(p=0.003)。总体而言,我们的研究结果表明,早期外周血 IFN-β水平可能是住院 COVID-19 成年患者进一步需要 ICU 收治的一个相关预测标志物,特别是在入院时临床评分(NEWS)被评为大于 5 分时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/2a1f91647674/JMV-95-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/68f90eae5c7f/JMV-95-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/f763073fbe6f/JMV-95-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/2a1f91647674/JMV-95-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/68f90eae5c7f/JMV-95-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/f763073fbe6f/JMV-95-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34e5/9877952/2a1f91647674/JMV-95-0-g001.jpg

相似文献

1
Early plasma interferon-β levels as a predictive marker of COVID-19 severe clinical events in adult patients.早期血浆干扰素-β水平可作为预测成年 COVID-19 患者严重临床事件的标志物。
J Med Virol. 2023 Jan;95(1):e28361. doi: 10.1002/jmv.28361.
2
The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染住院患者的国家早期预警评分和国家早期预警评分 2 的性能。
Resuscitation. 2021 Feb;159:150-157. doi: 10.1016/j.resuscitation.2020.10.039. Epub 2020 Nov 8.
3
[The predictive value of warning scores for intensive care unit admission in coronavirus disease 2019 patients].[2019冠状病毒病患者重症监护病房入院预警评分的预测价值]
Zhonghua Nei Ke Za Zhi. 2023 Apr 1;62(4):433-437. doi: 10.3760/cma.j.cn112138-20220414-00277.
4
Early warning scores to assess the probability of critical illness in patients with COVID-19.用于评估 COVID-19 患者发生危重症可能性的早期预警评分。
Emerg Med J. 2021 Dec;38(12):901-905. doi: 10.1136/emermed-2020-211054. Epub 2021 Oct 27.
5
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores.利用早期预警评分预测急诊科 COVID-19 患者的重症监护病房收治和死亡。
Resuscitation. 2020 Nov;156:84-91. doi: 10.1016/j.resuscitation.2020.08.124. Epub 2020 Sep 9.
6
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection.国家早期预警评分 2(NEWS2)对 SARS-CoV-2 感染患者入住重症监护病房的预测价值。
Infect Dis (Lond). 2020 Oct;52(10):698-704. doi: 10.1080/23744235.2020.1784457. Epub 2020 Jun 25.
7
National early warning score to predict intensive care unit transfer and mortality in COVID-19 in a French cohort.国家早期预警评分预测 COVID-19 患者转入重症监护病房和死亡的风险:一项法国队列研究。
Int J Clin Pract. 2021 Jun;75(6):e14121. doi: 10.1111/ijcp.14121. Epub 2021 Mar 9.
8
Multicenter validation of Early Warning Scores for detection of clinical deterioration in COVID-19 hospitalized patients.多中心验证预警评分对 COVID-19 住院患者临床恶化的检测。
Med Intensiva (Engl Ed). 2023 Jan;47(1):9-15. doi: 10.1016/j.medine.2021.11.023. Epub 2022 Oct 19.
9
Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.氧化应激和炎症生物标志物可预测 COVID-19 住院患者的病情严重程度和 ICU 收治情况。
Int J Mol Sci. 2021 Jul 12;22(14):7462. doi: 10.3390/ijms22147462.
10
Using the National Early Warning Score (NEWS/NEWS 2) in different Intensive Care Units (ICUs) to predict the discharge location of patients.使用国家早期预警评分(NEWS/NEWS 2)在不同的重症监护病房(ICU)预测患者的出院地点。
BMC Public Health. 2019 Sep 5;19(1):1231. doi: 10.1186/s12889-019-7541-3.

引用本文的文献

1
Aggravating mechanisms from COVID-19.COVID-19 的加重机制。
Virol J. 2024 Sep 27;21(1):228. doi: 10.1186/s12985-024-02506-8.
2
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblasts.B-ALL 细胞中的线粒体双链 RNA 可刺激间充质基质细胞成为癌相关成纤维细胞。
Blood Adv. 2024 Nov 12;8(21):5696-5709. doi: 10.1182/bloodadvances.2023012077.
3
Nutritional and Inflammatory Markers Associated with SARS-CoV-2 Infection in the Elderly.与老年人感染 SARS-CoV-2 相关的营养和炎症标志物。

本文引用的文献

1
Toll-like receptor 4 in COVID-19: friend or foe?新型冠状病毒肺炎中的Toll样受体4:是友还是敌?
Future Virol. 2022 Mar. doi: 10.2217/fvl-2021-0249. Epub 2022 Apr 19.
2
Distinct cytokine profiles associated with COVID-19 severity and mortality.与 COVID-19 严重程度和死亡率相关的独特细胞因子谱。
J Allergy Clin Immunol. 2021 Jun;147(6):2098-2107. doi: 10.1016/j.jaci.2021.03.047. Epub 2021 Apr 22.
3
In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.关于 SARS-CoV-2 mRNA 在人类细胞内 TLR 上的比较感应的计算机分析。
Int J Mol Sci. 2024 Jul 15;25(14):7749. doi: 10.3390/ijms25147749.
4
Endothelial dysfunction and persistent inflammation in severe post-COVID-19 patients: implications for gas exchange.重症新冠病毒感染后患者的内皮功能障碍和持续炎症:对气体交换的影响
BMC Med. 2024 Jun 13;22(1):242. doi: 10.1186/s12916-024-03461-5.
5
SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice.当 SARS-CoV-2 在免疫幼稚的小鼠中反复传代时,会迅速进化出谱系特异性的表型差异。
Commun Biol. 2024 Feb 16;7(1):191. doi: 10.1038/s42003-024-05878-3.
6
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review.干扰素 β 在多发性硬化症中的价值及抗病毒活性的新机遇:一篇叙事性文献综述。
Front Immunol. 2023 Jun 2;14:1161849. doi: 10.3389/fimmu.2023.1161849. eCollection 2023.
J Med Virol. 2021 Apr;93(4):2476-2486. doi: 10.1002/jmv.26776. Epub 2021 Jan 12.
4
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
5
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
6
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores.利用早期预警评分预测急诊科 COVID-19 患者的重症监护病房收治和死亡。
Resuscitation. 2020 Nov;156:84-91. doi: 10.1016/j.resuscitation.2020.08.124. Epub 2020 Sep 9.
7
Activation and evasion of type I interferon responses by SARS-CoV-2.SARS-CoV-2 激活和逃避 I 型干扰素应答。
Nat Commun. 2020 Jul 30;11(1):3810. doi: 10.1038/s41467-020-17665-9.
8
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
9
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.基于 SARS-CoV-2 刺突糖蛋白与 ACE-2 受体同源物和人类 TLR 相互作用的比较特征的计算机研究。
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.
10
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下:一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.